KIAA1755 and B-cell chronic lymphocytic leukemia: In addition, by analyzing the combined expression of lnc-IRF2-3 and lnc-KIAA1755-4, we aimed to test the above-mentioned “2-lncRNA risk model” in a heterogeneous CLL cohort.